Jason Cohen, Editor

About the Author Jason Cohen, Editor


Aegis Drops Coverage of IntelliPharmaCeutics Intl Inc (USA) (IPCI)

In a note issued short while ago, Aegis analyst Difei Yang dropped coverage of IntelliPharmaCeutics Intl …

Read more

Cytokinetics, Inc.’s (CYTK) CK-107 Could Benefit from SMA Demand

H.C. Wainwright analyst Joseph Pantginis is out today with a research note on Cytokinetics, Inc. …

Read more

Bullish Sentiment In Akari Therapeutics PLC (ADR) (AKTX) Reverses; Chardan Sees 63% Downside for the Stock

After a 200% rally in less than a month, Akari Therapeutics PLC (ADR) (NASDAQ:AKTX) shares tumbled nearly …

Read more

Here’s Why Maxim Slashed Price Target on Achillion Pharmaceuticals, Inc. (ACHN) Today

Maxim analyst Jason Kolbert slashes his price target on shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) to …

Read more

Everything You Need to Know Ahead of Gilead Sciences, Inc. (GILD) Q1:17 Earnings

Gilead Sciences, Inc. (NASDAQ:GILD) hepatitis C franchise will again be in the spotlight when the …

Read more

Top Analyst Cuts Price Target on Valeant Pharmaceuticals Intl Inc (VRX), Bumps Up on Endo International plc (ENDP)

Based on recent prescription data, Mizuho’s top analyst Irina Rivkind Koffler is out with a few updates on beaten-down …

Read more

Endo International plc (ENDP) Long-Term Strategy Remains Unclear

Canaccord analyst Dewey Steadman is out with a research note on shares of Endo International plc …

Read more

Cantor Makes Bullish Case for Aurinia Pharmaceuticals Inc (AUPH); Shares Rise

Cantor analyst Elemer Piros initiates coverage on shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), with an Overweight rating and …

Read more

FBR Reiterates Bullish Stance On Aurinia Pharmaceuticals Inc (AUPH) Following Development Updates

In a research report released Friday, FBR analyst Vernon Bernardino reiterated an Outperform rating on …

Read more

This Analyst Sees Over 200% Upside For Rexahn Pharmaceuticals, Inc. (RNN) Shares

In a research report issued Thursday, H.C. Wainwright analyst Joseph Pantginis assumed coverage on shares of …

Read more